The state of Oklahoma currently has 1 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Oklahoma City, Tulsa, Norman and Edmond.
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Recruiting
This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424, 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.
Gender:
ALL
Ages:
30 years and above
Trial Updated:
12/19/2024
Locations: The Movement Disorder Clinic of Oklahoma, Tulsa, Oklahoma
Conditions: Parkinson Disease